National Pension Service increased its stake in Xylem Inc. (NYSE:XYL - Free Report) by 18.1% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 356,906 shares of the industrial products company's stock after purchasing an additional 54,648 shares during the quarter. National Pension Service owned 0.15% of Xylem worth $42,636,000 at the end of the most recent quarter.
A number of other large investors have also made changes to their positions in XYL. Townsquare Capital LLC increased its holdings in shares of Xylem by 0.8% in the 4th quarter. Townsquare Capital LLC now owns 11,074 shares of the industrial products company's stock valued at $1,285,000 after purchasing an additional 88 shares in the last quarter. Bridgewater Associates LP increased its holdings in Xylem by 59.6% during the 4th quarter. Bridgewater Associates LP now owns 2,482 shares of the industrial products company's stock valued at $288,000 after acquiring an additional 927 shares in the last quarter. Evergreen Capital Management LLC increased its holdings in Xylem by 3.6% during the 4th quarter. Evergreen Capital Management LLC now owns 5,585 shares of the industrial products company's stock valued at $648,000 after acquiring an additional 193 shares in the last quarter. NewEdge Advisors LLC increased its holdings in Xylem by 2.9% during the 4th quarter. NewEdge Advisors LLC now owns 4,019 shares of the industrial products company's stock valued at $466,000 after acquiring an additional 112 shares in the last quarter. Finally, CANADA LIFE ASSURANCE Co increased its holdings in Xylem by 14.3% during the 4th quarter. CANADA LIFE ASSURANCE Co now owns 394,953 shares of the industrial products company's stock valued at $45,803,000 after acquiring an additional 49,460 shares in the last quarter. Hedge funds and other institutional investors own 87.96% of the company's stock.
Xylem Trading Up 0.0%
Xylem stock traded up $0.0010 during trading on Wednesday, reaching $141.8310. The company had a trading volume of 659,225 shares, compared to its average volume of 1,468,926. Xylem Inc. has a 12-month low of $100.47 and a 12-month high of $145.33. The stock's 50 day moving average price is $133.35 and its two-hundred day moving average price is $126.12. The firm has a market capitalization of $34.52 billion, a price-to-earnings ratio of 36.83, a PEG ratio of 2.44 and a beta of 1.11. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.43 and a current ratio of 1.90.
Xylem (NYSE:XYL - Get Free Report) last released its earnings results on Thursday, July 31st. The industrial products company reported $1.26 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.15 by $0.11. Xylem had a net margin of 10.74% and a return on equity of 10.33%. The firm had revenue of $2.30 billion during the quarter, compared to the consensus estimate of $2.20 billion. During the same period in the previous year, the firm earned $1.09 earnings per share. Xylem's revenue was up 6.1% compared to the same quarter last year. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. As a group, equities analysts expect that Xylem Inc. will post 4.65 earnings per share for the current fiscal year.
Xylem Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Thursday, August 28th will be paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 1.1%. The ex-dividend date is Thursday, August 28th. Xylem's payout ratio is currently 41.56%.
Analyst Ratings Changes
Several research firms have weighed in on XYL. Stifel Nicolaus raised their target price on shares of Xylem from $162.00 to $175.00 and gave the company a "buy" rating in a report on Friday, August 1st. Robert W. Baird cut their price objective on shares of Xylem from $149.00 to $146.00 and set an "outperform" rating for the company in a research report on Wednesday, April 30th. Royal Bank Of Canada boosted their price objective on shares of Xylem from $143.00 to $147.00 and gave the company an "outperform" rating in a research report on Wednesday, April 30th. Wall Street Zen raised shares of Xylem from a "hold" rating to a "buy" rating in a research report on Saturday, August 9th. Finally, JPMorgan Chase & Co. assumed coverage on shares of Xylem in a research report on Friday, May 30th. They issued an "overweight" rating and a $148.00 price objective for the company. Six investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. Based on data from MarketBeat, Xylem has an average rating of "Moderate Buy" and a consensus price target of $151.57.
View Our Latest Stock Report on Xylem
Xylem Profile
(
Free Report)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Recommended Stories

Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.